![]() CME Symposium- Managing LDL-C with PCSK9 Inhibitors: Identifying the Patients, Optimizing the OutcomesThis CME Symposium takes place on Friday, February 22, 2019, from 6:45 PM- 9:00 PM at the Hilton Portland Downtown, Galleria Ballroom, 921 SW Sixth Avenue, Portland, Oregon.
By: Voxmedia LLC LDL-cholesterol (LDL-C) is a central focus of cardiovascular risk reduction. Prudent use of PCSK9 inhibitors requires the identification of patients with elevated LDL-C at increased cardiovascular risk. High-risk patients include those with atherosclerotic cardiovascular disease (ASCVD) and those with LDL-C ≥ 190 mg/dL without ASCVD. Awareness of the evidence with PCSK9 inhibitors, discussions of best use of these agents by lipid experts, and interactive case presentations aim to facilitate treatment by lipidologists of appropriate patients with these drugs to optimize clinical outcomes. In this program, Chair Dr. James Underberg, and faculty members Dr. Ty Gluckman, Dr. Margo Minissian, Dr. Michael Shapiro, and Dr. Pam Taub, will use these educational formats to assist lipidologists in patient management with PCSK9 inhibitors. Chair: James Underberg, MD, MS Clinical Assistant Professor of Medicine New York University School of Medicine New York, New York Faculty: Ty Gluckman, MD Medical Director, Center for Cardiovascular Analytics, Research, and Data Science Providence Heart Institute Providence St. Joseph Health Portland, Oregon Margo Minissian, PhD, ACNP, CLS, AACC Nurse Scientist, Cardiology Nurse Practitioner Barbra Streisand Women's Heart Center Smidt Heart Institute Cedars-Sinai Medical Center Los Angeles, California Michael Shapiro, DO Associate Professor of Medicine and Radiology Oregon Health & Science University Portland, Oregon Pam Taub, MD Associate Professor of Medicine University of California San Diego La Jolla, California The National Lipid Association and Voxmedia International gratefully acknowledges the educational grant supported by Amgen. This activity is designed to meet the needs of lipidologists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management. Pre-registration is for planning purposes only. For additional CME activities and online cme courses visit CMEPlanet End
|